Human Gene Therapy

Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1

Avani V. Mylvara 1, 2
, 
Cristin D. Davidson 1
, 
Derek Alexander 1
, 
Charles P. Venditti 2
, 
Forbes D. Porter 1
1
 
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Human Health and Services, Bethesda, Maryland, USA
2
 
National Human Genome Research Institute, National Institutes of Health, Department of Human Health and Services, Bethesda, Maryland, USA.
Publication type: Journal Article
Publication date: 2025-02-27
scimago Q2
SJR: 1.091
CiteScore: 6.5
Impact factor: 3.9
ISSN: 10430342, 15577422
Found 0
By date By citations
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex
Found error?